Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic paravertebral block plus hydromorphone PCIA vs hydromorphone PCIA alone after thoracoscopic surgery
ChiCTR2300074082Phase 4Not yet recruiting
- Sponsor
- Shifang People's Hospital
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in bronchial carcinoma and postoperative pain (2 arms), sponsored by Shifang People's Hospital. Primary endpoints: VAS scores and BCS scores. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
bronchial carcinomapostoperative pain
Beyond the preview
Go deeper on ChiCTR2300074082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074082.